An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

Antony W Burgess1, Hyun-Soo Cho, Charles Eigenbrot

  • 1Cooperative Research Centre for Cellular Growth Factors, P.O. Box 2008, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia.

Molecular Cell
|October 7, 2003
PubMed

Insights

Recent studies reveal how Epidermal Growth Factor Receptor (EGFR) family kinases dimerize upon growth factor binding. This insight into ErbB receptor regulation offers new strategies for targeting cancers driven by these pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Receptor tyrosine kinases (RTKs) are crucial cell signaling proteins.
  • The Epidermal Growth Factor Receptor (EGFR) or ErbB family plays key roles in cell growth and cancer.
  • Understanding RTK regulation is vital for developing targeted therapies.

Purpose of the Study:

  • To elucidate the structural mechanisms of ErbB receptor dimerization.
  • To explain the unique properties of ErbB2 due to its constitutive dimerization.
  • To propose novel therapeutic strategies targeting ErbB-mediated signaling in cancer.

Main Methods:

  • Analysis of recent crystallographic studies on EGFR/ErbB family receptors.
  • Investigation of growth factor-induced domain rearrangements.
  • Comparative analysis of ligand-dependent and ligand-independent dimerization.

Main Results:

  • EGF receptor dimerization requires growth factor binding to expose a unique dimerization arm.
  • ErbB2 exhibits constitutive dimerization due to a permanently exposed dimerization arm.
  • These findings provide a mechanistic basis for ErbB receptor homo- and heterodimerization.

Conclusions:

  • A mechanistic model for ErbB receptor dimerization has been established.
  • The constitutive dimerization of ErbB2 explains its distinct biological functions.
  • This research suggests new therapeutic avenues for interfering with oncogenic ErbB signaling pathways.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...